1-Butanol, 4-[(5,6-diphenyl-2-pyrazinyl)amino]-

Uses

4-((5,6-Diphenylpyrazin-2-yl)amino)butan-1-ol is a selexipag impurity (S253150). Selexipag is an orally available, highly selective, long-acting prostacyclin (IP) receptor agonist prodrug. It is a potential drug for the treatment of various vascular disorders such as pulmonary arterial hypertension and arteriosclerosis obliterans.